Brickell biotech, inc. (VICL)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue from Contract with Customer, Excluding Assessed Tax

1,046

3,242

1,183

0

3,492

6,415

3,042

725

706

-

3,188

3,369

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

2,901

-

2,310

3,630

4,088

6,478

4,427

3,681

4,274

-

3,004

3,951

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract and grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,118

-

1,311

1,170

1,136

1,909

1,682

1,364

1,221

1,616

1,360

717

530

1,573

1,379

License and royalty revenue

-

-

-

0

-

-

-

10

10

10

52

52

304

387

332

492

516

335

590

495

670

592

438

554

329

916

232

286

438

410

493

201

10,239

316

25,259

101

119

684

696

Total revenues

-

-

-

0

-

-

-

735

716

3,953

3,240

3,421

3,205

3,163

2,642

4,122

4,604

6,813

5,017

4,176

4,944

4,823

3,442

4,505

2,447

3,145

1,543

1,456

1,574

2,319

2,175

1,565

11,460

1,932

26,619

818

649

2,257

2,075

Operating expenses:
Research and development

2,664

10,099

3,337

759

6,019

1,559

4,135

3,602

3,664

4,448

3,004

3,639

3,300

2,975

2,599

2,303

2,478

2,839

2,128

2,457

3,637

3,762

3,180

2,379

2,146

2,478

4,500

3,930

3,650

3,439

3,682

3,791

6,428

3,971

5,505

4,209

4,290

4,658

4,963

Manufacturing and production

-

-

-

0

-

-

-

0

1,436

1,790

1,778

1,602

1,309

1,231

993

1,221

2,846

4,301

1,306

2,379

2,941

3,367

2,292

3,650

1,515

1,194

3,900

3,891

3,713

3,797

3,853

2,933

2,472

2,570

2,343

2,606

2,748

2,307

3,431

General and administrative

2,481

3,962

3,901

2,242

2,066

795

1,206

2,261

2,117

1,596

1,639

1,591

1,509

1,732

1,621

1,919

1,790

2,095

1,916

2,132

2,223

2,376

2,366

2,541

2,269

1,695

3,123

3,478

3,518

2,659

2,420

2,778

2,700

2,437

2,379

2,454

2,328

2,102

2,186

Total operating expenses

-

-

-

3,001

-

-

-

5,863

7,217

7,834

6,421

6,832

6,118

5,938

5,213

5,443

7,114

-

5,350

6,968

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

5,145

-

7,238

-

8,085

-

5,341

-

-

-

-

-

-

-

-

-

-

-

-

-

8,801

-

7,838

8,570

5,930

5,367

11,523

11,299

10,881

9,895

9,955

9,502

11,600

8,978

10,227

9,269

9,366

9,067

10,580

Loss from operations

-4,099

-10,819

-6,055

-3,001

-4,593

5,477

-2,299

-5,128

-6,501

-3,881

-3,181

-3,411

-2,913

-2,775

-2,571

-1,321

-2,510

-2,422

-333

-2,792

-3,857

-4,682

-4,396

-4,065

-3,483

-2,222

-9,980

-9,843

-9,307

-7,576

-7,780

-7,937

-140

-7,046

16,392

-8,451

-8,717

-6,810

-8,505

Investment and other income (loss), net

-4

-

54

-

6

-

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-

-

2,318

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment and other income, net

-

-

-

571

-

-

-

260

231

153

93

91

89

3

48

66

87

67

33

30

36

49

32

25

28

-

97

-

-

-

-

-

-

-

-

-

-

-

-

Investment and other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-38

25

-

54

69

-

-

-

-

-

-

-

Investment and other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-384

-

-39

-45

-23

-43

-125

Interest expense

0

-

1,098

-

224

-

267

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities, Fair Value Adjustment

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

0

-

0

-

-231

-

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-4,100

-12,109

-4,781

-2,430

-4,580

4,443

-2,541

-4,868

-6,270

-3,728

-3,088

-3,320

-2,824

-2,772

-2,523

-1,255

-2,423

-2,355

-300

-2,762

-3,821

-4,633

-4,364

-4,040

-3,455

-2,192

-9,883

-9,881

-9,282

-7,549

-7,726

-7,868

244

-6,614

16,431

-8,406

-8,694

-6,767

-8,380

Reduction of redeemable convertible preferred stock to redemption value

0

-

82

-

-10,519

-

966

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) attributable to common stockholders

-4,103

-

-4,863

-

5,939

-

-3,507

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share share attributable to common stockholders, basic (in usd per share)

-0.45

-12.82

-1.65

-0.11

10.08

-19.36

-5.98

-0.22

-0.29

-0.19

-0.27

-0.30

-0.25

-0.26

-0.24

-0.14

-0.26

-0.64

-0.03

-0.30

-0.04

-1.72

-0.05

-0.05

-0.04

-0.03

-0.11

-0.11

-0.11

-

-0.09

-0.09

-

-

-

-0.12

-

-

-0.15

Basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

0.23

-

-0.12

-0.12

-

Net income (loss) per common share attributable to common stockholders, diluted (in usd per share)

-0.45

-

-

-

-2.48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

0.22

-

-0.12

-0.12

-

Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares)

9,106

-14,265

2,943

22,825

589

-41,903

586

21,837

21,828

17,854

11,458

11,139

11,101

11,166

10,453

9,240

9,217

-72,555

9,196

9,189

90,870

-228,889

89,976

87,319

87,110

86,994

86,998

86,730

86,638

-

86,408

86,282

-

-

-

71,961

-

-

56,369

Weighted average shares used in computing basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

84,519

-

72,075

-

71,893

56,745

-

Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, diluted (in shares)

9,106

-

-

-

1,845

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

86,124

-

73,739

-

71,893

56,745

-

Comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,774

-8,229

-8,736

-

-